Fight against COVID-19
Diagnostic antibody & antigen
Services
- Custom AAV Production
- Custom Adenovirus Production
- Custom Lentivirus Production
- Pre-made AAV Production
- Pre-made Adenovirus Production
- Pre-made Lentivirus Production
- AAV-LC3 Autophagy Flux Detection
- Ad-LC3 Autophagy Flux Detection
- Lv-LC3 Autophagy Flux Detection
- AAV Control Virus Production
- CRISPR/Cas9 AAV Production
- CRISPR/Cas9 Adenovirus Production
Supports
SOCAIL MEDIA
Liraglutide (5-31) TFA / Liraglutide (8-31) TFA (Victoza, GLP-1 receptor agonist)-Therapeutic peptides drug benchmark for in-vivo/in-vitro study
Cat No.: GMP-Bios-peptide-003 (GMP-Bios-peptide-003-1 / GMP-Bios-peptide-003-2) Product Name: Liraglutide (5-31) TFA / Liraglutide (8-31) TFA Structural formula:
Liraglutide TFA, the trifluoroacetic acid salt form of Liraglutide. Liraglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist also known as incretin mimetics. Liraglutide, sold under the brand name Victoza among others, is an anti-diabetic medication used to treat type 2 diabetes, obesity, and chronic weight management. It works by increasing insulin release from the pancreas and decreases excessive glucagon release. Liraglutide was approved for medical use in the European Union in 2009, and in the United States in 2010.
Order information
| Catalog No. | Desciption | Price(In USD) | Qty (Quantity) | Sum(In USD) |
|---|---|---|---|---|
| GMP-Bios-peptide-003-1-5mg | Liraglutide (5-31) TFA Size:5mg | 780 | ||
| GMP-Bios-peptide-003-1-25mg | Liraglutide (5-31) TFA Size:25mg | 1950 | ||
| GMP-Bios-peptide-003-1-50mg | Liraglutide (5-31) TFA Size:50mg | 2925 | ||
| GMP-Bios-peptide-003-1-100mg | Liraglutide (5-31) TFA Size:100mg | 3900 | ||
| GMP-Bios-peptide-003-1-500mg | Liraglutide (5-31) TFA Size:500mg | 7800 | ||
| GMP-Bios-peptide-003-2-5mg | Liraglutide (8-31) TFA Size:5mg | 780 | ||
| GMP-Bios-peptide-003-2-25mg | Liraglutide (8-31) TFA Size:25mg | 1950 | ||
| GMP-Bios-peptide-003-2-50mg | Liraglutide (8-31) TFA Size:50mg | 2925 | GMP-Bios-peptide-003-2-100mg | Liraglutide (8-31) TFA Size:100mg | 3900 | GMP-Bios-peptide-003-2-500mg | Liraglutide (8-31) TFA Size:500mg | 7800 |
| GMP-Bios-peptide-003-1/2-xmg | Size≥500mg | Inquiry | ||
| Shipping Cost: | 760.00 | |||
| Total: | ||||
Description
| Product Name | Liraglutide (5-31) TFA / Liraglutide (8-31) TFA |
| Brand name | Victoza |
| CAS No. | 204656-20-2 |
| Formula | C157H247N37O44 • C2HF3O2 / C140H224N34O39 • C2HF3O2 |
| Biological Activity | Liraglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist also known as incretin mimetics. |
| Purity | Purity: ≥98% (HPLC) |
| Application | Therapeutic peptides drug benchmark or raw material for peptide drugs or peptide conjugation drugs discovery and development. |
| Predicted Molecular Mass | 3356.86 / 3007.48 |
| Formulation | Powder |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
- GENEMEDI
- Email: [email protected] [email protected]
- Telephone: +86-21-50478399 Fax: 86-21-50478399
- Privacy Policy
- TECHNICAL SUPPORT
- Product FAQs
- Technical manuals
- Publications
- Email: [email protected]
<